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Summary 
Mice expressing the minor lymphocyte stimulation antigens, Mls-1 a, -2  a, or -3  ~, singly on the 
B10.BR background have been generated. Mls phenotypes correlate with the integration of mouse 
mammary tumor viruses  (MTV) in the mouse genome. The open reading frames within the 
3' long terminal repeats of the integrated MTVs 1, 3, 6, and 13 encode V~3-specific superantigens. 
Sequence data for these viral superantigens is presented, indicating that it is the COOH-terminal 
portion of the viral  superantigen that interacts with the T  cell receptor VB element. 
A  number of murine aUoantigens have been described that, 
in combination with MHC class II products, stimulate 
T cells bearing particular V3 elements (1-8).  These alloan- 
tigens have been termed superantigens (9). Mice expressing 
such superantigens delete thymocytes bearing reactive V3 ele- 
ments during development in the thymus (10). This clo- 
nal elimination of thymocytes maintains self-tolerance  by 
preventing mature self-reactive T cells from reaching the pe- 
riphery. 
The analysis of peripheral expression ofT cells bearing par- 
ticular V3 elements has recently facilitated the mapping of 
several of these superantigens to particular chromosomal lo- 
cations. Woodland et al. (11, 12) found no recombinants be- 
tween the gene encoding a superantigen (Etc-1), which causes 
deletion of V/~11- and VB5.2-bearing T cells, and a mouse 
mammary tumor virus (MTV) 1 integrant (Mtv-9) on chro- 
mosome 12. In addition, the genes for several other endoge- 
nous mouse superantigens map to the same chromosomal 
regions as MTV integrants (4, 13, 14). In the past, however, 
some recombinants between the genetic locations of mouse 
endogenous superantigens and Mtvs had been reported in the 
AKXD and BXD recombinant inbred mice. Suspecting that 
these reported recombinants may have been mistyped, Frankel 
et al. (15) retyped the collection of AKXD and BXD mice 
for MTV integrants and, after correcting previous typings, 
1 Abbreviations  used in  this  paper: LTR,  long  terminal  repeat;  MTV, 
mammary  tumor  virus;  ORF,  open  reading  frame;  VSAG,  viral 
superantigens. 
found perfect correlation between the expression of several 
superantigens and presence of particular MTV integrants in 
these mice. Thus, these investigators  suggested that MTV 
integrants themselves code for the endogenous mouse super- 
antigens. Independently, Dyson et al. (16) arrived at the same 
conclusion after mapping several ligands that delete Vf111  + 
T  cells. 
Recently, we have shown that the infectious milk-borne 
MTV carried by C3H/HeJ mice codes for a superantigen 
that interacts with T  cells bearing Vf114 and -15 (17, 18). 
Furthermore, transfection experiments have shown that it is 
the product of the open reading frame (ORF) within the 
3' long terminal repeat (LTR) of the C3H MTV that confers 
the ability to interact with TCK in a V~-specific manner (18). 
Acha-Orbea et al. (19) have shown, using a transgenic model, 
that the OKF of the infectious MTV transmitted in the milk 
of GR mice also causes deletion of Vf114  § thymocytes. We 
have suggested the name viral superantigen (vSAG) for these 
ORF genes. 
In this study, we have used mice expressing Mls-1 a -2  a, 
or -3  a singly on the B10.BR background to demonstrate 
conclusively the correlation between the expression of these 
Mls phenotypes and the presence of Mtv-7, -1, and -6 (vSAG-7, 
-1, and -6), respectively. Transfection experiments showed that 
Mtv-1 and Mtv-3 vSAGs encode Vfl3-specific superantigens. 
The sequences presented here for the MTV vSAGs with Vfl3 
specificity (Mtv-1, -3, -6, and -13) strengthen the hypothesis 
that it is the COOH-terminal region of the vSAG that in- 
teracts  with the TCR Vfl. 
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Mice.  Mice  were generally purchased from The Jackson Labo- 
ratory (Bar Harbor, ME). Mice carrying Mls-l', Mls-2  ', or Mls-32 
on the B10.BR background were bred in our own facility. 
Flow Cytometric Analyses.  Nylon  wool-purified,  peripheral 
blood and lymph node T cells were analyzed for expression  of  VB3 
and Vfl6 as outlined previously (9). T cells were stained with bi- 
otinylated KJ25 (anti-V133; reference  4) or RR4-7 (anti-V136; refer- 
ence 20) followed  by PE-streptavidin  (Tago  Inc., Burlingame, CA). 
Two-color analyses  of TCR VI3 expression and CD4 and/or CD8 
used directly fluoresceinated  GK1.5 (21) and 53.6.71 (22), respec- 
tively. 
Southern Analyses.  Liver  or tail DNA was digested with PvuII, 
subjected to dectrophoresis on 0.7% agarose gels, and transferred 
to nitrocellulose as described by Maniatis et al. (23). Filters were 
hybridized with a MTV LTK probe. The probe was an EcoRI- 
BamHI fragment of pTZ18R-ORF (18), derived from the milk- 
borne C3H MTV (kindly  provided  by Dr. John Majors, Washington 
University School of Medicine, St. Louis, MO).  The probe was 
labeled by random priming (24). Filters were washed with two 
final washes with 0.1% SSC, 0.1% SDS at 58~  for 30 min. 
PCR Amplification, Clonin,~  and Sequencing  of  MTV uSAGs.  Oli- 
gonucleotide primers specific for  C3H  MTV  vSAG (5'  sense, 
GGGAATTCTCGAG~GCCGCGCCTGCAG;  and 3' antisense, 
~ATCCAACTAACTTAAACCTTGG) were used to amplify 
the vSAGs from PvulI-digested genomic DNA from DBA/2 and 
C58 mice. The DNA was separated on a 0.7%  agarose gel and 
gel pieces corresponding to the 3' LTKs of Mtu-1, -6, and -13 from 
DBA/2 and Mtv-3 from C58 (Fig. 1) were excised. DNA purified 
using Geneclean  (Bio 101 Inc., LaJolla, CA) was subjected  to PCR 
amplification using a thermocycler (Cetus Corp., Norwalk,  CT) 
and the following amplification  conditions: 95*C melting, 50~ 
annealing, and 72~  extension,  each for 2 rain. The amplified  prod- 
ucts  were restricted with BamHI  and  EcoRI  and cloned into 
pTZ18R. Multiple clones were sequenced  by the chain termination 
method (25) using the Sequenase kit (United States Biochemical 
Corp.,  Cleveland, OH). 
Transfection.  The vSAGs of  Mtv-1 and Mtv-3 were subsequently 
cloned into the eukaryotic expression vector pBDWMCI32 (26). 
In case other retroviral products were necessary  to ensure high ex- 
pression of the vSAG  products, the vSAG  constructs were cotrans- 
fected with pUVH, a plasmid containing the 5' sequences of the 
endogenous C3H provirus Mtv-1 and the Y sequences of the milk- 
borne exogenous C3H MTV (27). These plasmids were linearized 
with XbaI and Sall respectively,  and were transfected into the B 
ceU line CH12.1 (28) by dectroporation. Transfectants  were selected 
with G418. 
Stimulation Assays,  Transfectants  were screened  for their ability 
to stimulate T cell hybrids expressing V133 (K25-49.16 and K25- 
59.6; reference 4) and Vfl7 (KOXY-6.6; reference 18). 105 B cell 
transfectants were cultured with 105 T ceU hybrids. Lymphokine 
production  was assayed after 24 h using the indicator cell line 
8"i"-2 (29). 
Results and Discussion 
Endogenous Mouse Superantigens Map to MTV Integration 
Sites.  Previously published  analysis  of the  progeny of a 
(C3H/HeJ  x  B10.BR)F1  x  B10.BR backcross  has shown 
that C3H/HeJ mice express two V133-specific superantigens, 
Mls-2  a and Mls-3  a (30).  The progeny that expressed Mls-2 a 
or Mls-3  a were further backcrossed  on to the B10.BR back- 
ground. For each generation, the offspring were screened for 
Vt33 expression and the mice expressing low levels of V133 + 
peripheral blood T  cells were used as breeders.  Expression 
of Mls-2  ~ causes  partial deletion of V133  +  T  cells,  while 
Mls-3  ~ causes complete deletion of these cells (Table 1; and 
reference 30). Fig. 2 shows a Southern blot of genomic DNA 
from the backcrossed  mice hybridized with a probe derived 
from  C3H  exogenous  MTV  LTR.  Mice  expressing  the 
Mls-2  a phenotype carried Mtv-1, while the Mls-3  ~ mice car- 
ried Mtv-6. This is a formal demonstration that the Mls-2' 
phenotype correlates with the presence ofMtv-1, a possibility 
suggested by Frankel et al.  (15). 
Concurrently, we have backcrossed the Mls genes of CBA/J 
on to the B10.BR background. Deletion of V136 + T  cells 
was used as a marker for Mls-P expression (3) and the ab- 
sence of V133-bearing cells was taken to indicate the presence 
of another Mls gene. Mls-P expression  correlates  with the 
Table  1.  V~3-specific  Deletion of T  Cells by Endogenous Mouse 
Superantigens 
Percent V/33  § 
Source of  lymph node 
Mls genes  T  cells 
Figure  1.  Southern blot of 
PvulI-digested  DNA from  DBA/2 
and C58 mice. The filter  was hy- 
bridized with  a probe derived 
from  C3H c:zogcnous  MTV LTR.. 
Arrow heads  designate  molecular 
weight markers of  23.5, 9.4, 6.6, 
















42  Mouse  Mammary  Tumor Virus Integrants Encode Vfl3-specific Superantigens Figure 2.  Endogenous  mouse  superantigens  map to MTV integration 
sites. A Southern  blot of Pvull-digested  DNA from  inbred and recom- 
binant mouse  strains was hybridized  with a probe derived  from  C3H ex- 
ogenous MTV LTR. The higher  molecular  weight  bands for C3H/HeJ 
are  faint  due  to  partial  degradation  of  the  DNA  sample.  MIs-la(CBA)  desig- 
nates  BI0.BR-MIs-I  ~  (F6),  MIs-3a(CBA) designates  BI0.BR-MIs-3~(F6), 
MIs-3a(C3H) designates  BI0.BK-MIs-3~(F6),  and MIs-2a(C3H) designates 
B10.BR-MIs-2a(F7).  Assignments  are  made for  the  MTV  integrants  that 
are  known to  be present  in these  mouse strains. 
presence of Mtv-7 on chromosome 1 (Fig. 2; and reference 
15). It has previously been reported that, unlike C3H/HeJ 
and DBA/2, CBA/J carries only one VB3-specific superan- 
tigen (31-33). The expression of this superantigen correlates 
with the presence of Mtv-6  (Table 1 and Fig. 2),  and it is 
therefore termed Mls-3  ~. 
Four Different MTV Integrants Encode V~3-specific Superan- 
tigens.  Analyses  of  VB3 expression in ILl mice of  the AKXD 
and BXD series suggested that DBA/2 mice carry at least 
two genes encoding V/33-spedfic superantigens (4, 14); one 
mapping to chromosome  4 and a second to chromosome 16. 
Reanalysis of these data and the MTV integration sites for 
the RI strains suggested that DBA/2 mice actually carry three 
VB3-specific superantigens,  Mls-2  a, Mls-3L and one other, 
mapping to the retroviral integrants Mtv-1, Mtv-6, and Mtv-13 
on chromosomes 7,  16,  and 4, respectively (15). There is, 
however, evidence for yet another endogenous mouse super- 
antigen that reacts with T ceils bearing V~3. Several  strains, 
including C58, NZB, NOD, and CE, have  low levels  of  V/33 
expression but do not carry  Mtvs 1, 6, or 13 (4, 15, 34). Fair- 
child et al. (35) have  recently demonstrated, by analyzing the 
progeny of a (B10.S(9R)  x  NOD)F1  x  B10.BR backcross, 
that the V~3 deletion phenotype of NOD mice corrdates 
with the presence of  Mtv-3 on chromosome 11. To study the 
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relationship between these four V/33-specific  MTV integrants, 
we cloned and sequenced the 3' LTV vSAGs of these viruses 
as described in Materials and Methods. 
The Mtv-1 vSAG sequence from DBA/2 (Fig. 3) differed 
from the published  sequence for Mtv-1 from C3H (36) at 
two positions; first by a C-G mutation in codon 55 resulting 
in a Pro-Ala substitution,  and second, by the insertion of a 
single base at the third position of codon 315. The resulting 
protein encoded by this ORF is therefore three amino acids 
longer.  Since Mtv-1  in  C3H  mice interacts  with  V~/3  + 
T  cells, it suggests that the terminal three amino acids of 
the Mtv-1 vSAG in DBA/2 are not required for T cell stimu- 
lation or, alternatively, it is possible that the published  se- 
quence for C3H Mtv-1  may be wrong. 
The Mtv-6 and Mtv-13 vSAGs were amplified from DNA 
from RI strains BXD-8 and BXD-1,  respectively. Each of 
these KI strains carries only one MTV integrant that encodes 
a V/~3-specific superantigen derived from DBA/2 (37). The 
Mtv-1  and Mtv-6 vSAG genes only differ by eight nucleo- 
tides (Fig. 3); however, it is striking that their amino acid 
sequences are identical.  This finding is surprising,  since it 
is known that the products of  these genes differ  in the e~dency 
with which they cause T cell deletion. Mice bearing Mtv-6 
completely delete  V~3 + T  cells, while Mtv-1 expression 
results in only partial  deletion of these T  cells (4,  14,  15, 
30). Perhaps differences elsewhere in the MTV genomes, or 
the different chromosomal  integration sites, cause expression 
of the various V/33-spedfic MTV superantigens in different 
tissues or at different levels. 
The Mtv-13 vSAG  differs  from that of  Mtv-1 by seven  nucleo- 
tides; five of these differences are silent and the other two 
result in amino acid differences at positions 28 and 45 (Fig. 
3). The similarity of  the three MTV integrants encoding V/33- 
specific superantigens derived from DBA/2 mice may  be due 
to the insertion of similar MTVs at distinct sites in the mouse 
genome, on chromosomes 16, 4, and 7, or alternatively, it 
may be due to the transfer of the provirus from one chro- 
mosomal location to another with subsequent  point mutations. 
The sequence of Mtv-3 vSAG from C58 differs from the 
Mtv-1  vSAG by 10 amino acids (Fig. 3). All these residues, 
except Thr at position 317, have  been found in other MTV 
vSAGs. Similar relationships between other MTV vSAGs can 
be observed in other published  sequences (38-41) (Fig. 4). 
On the whole, amino acids found substituted in one vSAG 
can also be found in other ORFs, suggesting the occurrence 
of multiple recombination events; possibly by recombination 
between milk-borne infectious viruses, or alternatively, by 
gene conversion between the integrated proviruses. 
Comparisons  of the published sequences of vSAGs from 
the exogenous C3H MTV (39) and integrated MTVs 1, 8, 
9, and 11 (36, 40, 41), led us to speculate that the 30 or so 
amino acid residues at the COOH-terminal of the vSAGs 
were responsible for the VB specificity (18). This was sup- 
ported by the demonstration by Acha-Orbea et al. (19) that 
transgenic mice expressing a variant of the C3H MTV did 
not  delete  V~14 +  T  cells, whereas  the wild-type virus, 
which differs from the variant at amino acids 288-315 of the 
ORF, dearly caused the deletion of V/314-bearing T  cells. 1  10  20  30  40 
MTVI  ATGCCGC~CTGCAGCAGAAA~CTCCCGJgGAGTGTCC  TACACTTA~GCAOC CAAGGGOTTGTTTCCCACCAAOGACGACCC~~C~~CCA 
M  P  R  L  O  Q  K  W  L  N  B  R  E  C  P  T  L  R  R  E  A  A  K  O  L  F  P  T  K  D  D  P  S  A  C  T  R  M  8  P 
~3  ........................................................................................................................ 
IgTV6  ...........................................................  ~  ............................................................ 
MTVI3  ..................................................................................  T ..................................... 
...........................  Z  ............ 
50  60  70  e0 
N'I~I  TCA~-~GACATAC~-A~1~J~TCT~C~CJ~ACTT~CAT&~CTC~JL~CT~"1~C~T&~~~~AC~~---AAT 
8  D  K  D  Z  L  I  L  C  C  K  L  G  I  A  L  L  C  L  G  L  L  G  B  V  A  V  R  A  R  R  A  L  T  L  D  S  F  N 
ITV3  .......................................................  ￿9  ................................................................ 
MTV6  ..... ￿9  ..................  ~  ................  ￿9  .................................................................  T ............ 
MTVZ3  ..............  O ............................................................................................  T ............ 
90  100  110  120 
NTV1  AACTC TTC-~'~xg~LILAGATTACAATC  TAAAC GATTC GGAGAAC  TCGACCTTC  CTCC~~C C~A~C~C  ~  C~  ~AC~C~AC C~C  ~C ~A~TA~ 
M  8  8  V  O  D  Y  N  L  N  D  S  E  M  8  T  F  L  L  O  0  O  P  Q  P  T  S  B  Y  K  P  H  R  L  C  P  S  E  I  E 
MTV3  .G  ............................  A ....................................................................  T .................... 
B  .........  N  ......................  F  ...... 
~6  ........ C ............................................................................................................... 
.........................  .  .............. 
MTVI3  ........................................................................................................................ 
130  140  150  160 
MTVI  ATAA~UgATGCTTOC  TAAAAACTATA'~"~-~'~-TACCAATGAGACCAATCCAATAGGTC  GATTA~~~  ~  ~-~-A~AC  TATA~AC~~ 
Z  R  M  L  A  K  N  Y  I  F  T  N  R  T  N  P  I  O  R  L  L  I  M  M  L  R  M  E  S  L  B  F  S  T  I  F  T  Q  I  0 
MTV3  ....................  T ...............  A ..............................  CT .................  A- .AC  ....... T .....  T ............... 
............  K  .........  T  .......  P  ......... 
MTV6  ....................  T ................................................................................................... 
N'I'VX  3  ....................  T ................................................................................................... 
170  180  190  200 
MTVI  AGOTTAOAAATOOGAATAGAAAATAGAAAGAGACOCTCAACC  TCAGTTGAAGAACAGGTGCAAOGACT~C  ~A~C  TA~~~G~~ 
R  L  l  M  O  I  l  N  R  K  R  R  8  T  S  V  E  E  0  V  Q  G  L  R  A  8  O  L  E  V  K  R  O  K  R  B  A  L  V  g 
MTV3  ...........................................................  A ........ OTT ....  A ............................................ 
.......................  L  T  .............. 
MTV6  .....................................................................  ￿9  .................................................. 
MTV~3  ........................................................................................................................ 
210  220  230  240 
MTVI  AT~  .CCAGGGAC TTATAOGGGACC  TTACATTTACAGACCAACAGACGCCCCGTTAC  CATATACAGGJ~GATATGATTTAAA~-~-~-~OATAGG~ACAG~ 
I  ￿9  D  R  W  W  0  P  O  T  Y  R  O  P  Y  I  Y  R  P  T  D  A  P  L  P  Y  T  O  g  Y  D  L  N  F  D  R  W  V  T  V 
MTV$  ...........  A ...................................  C ..............  T ......................................................... 
MTV6  ...............................................  C .....................  C .................................................. 
MTVX3  ...............................................  C .....................  C .................................................. 
o  ....................................... 
250  260  270  280 
MTVI  AACGGC TATAAAGTGTTATACAGATCCC  TCCCC TTTC GTGAAAGGC  TC  GCCAGAGC  TAGACC TCC  TTGG~~ ~~~C~CA~CA~T~A~T 
M  O  Y  K  V  L  Y  R  8  L  P  F  R  E  R  L  A  R  A  R  P  P  W  C  V  L  S  0  E  E  K  D  D  M  K  0  Q  V  H  D 
MTV3  ............................................  A ................................  AA ....  O .................................... 
..........................  T  ............. 
MTV6  ..............................................................  *  ......................................................... 
MTVZ3  ........................................................................................................................ 
390  300  310 
I~1~1  TATATTTATC  TAG6UgACAGGRATGATA  -  -  -  CATTGO  -  -  -AAAGTA'~-~-~ATAACAGTAOAOAGGA~GC  CAAAAGACATATAATA~TA~  ~CC  TTA~  ~-~  T~ 
Y  I  Y  L  O  T  G  M  Z  -  H  W  -  K  V  F  Y  N  8  R  E  E  A  K  R  H  I  I  E  H  I  X  A  L  P  L  A  F  * 
MTV3  ...........  G- -O  ...................................................................................  A .........  A ........ 
....................................  T 
MTV6  ...........  G- -O  ...................................................................................  A .................. 
MTVI3  ..................................................................................................  A  .................. 
Figure 3.  Sequences  of Vfl3-specitic  MTV viral superantigens.  Dashes designate spaces to allow alignment with the sequences  of the other MTV 
vSAGs as shown in Fig. 4. These sequence  data have been included in the EMBL Data Libraries under accession  numbers X63024 (MTV1), X63025 
(MTV3), X63026 (MTV6), and X63027 (MTV13). 
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(~llt~u.i  NPR]r,G~.~WIalBI%EC]PT~GL~' I~Iq.~DDpB,~kC-I'RMBp  JD][]DX LILIaCKLGIALLCLGLLG~VAV]Utat]RALT  LD~  ~N~B%,~]DTNLR~B]I~BT]~ LLGQG~I~jL~B~T~ 
NS~-C3H 
NTV-GR 
14,15  ................  P.O  ...............  ~  .........  F  ..................................  IS ..................  R  .......... 
14  ..................  O  ...............  I~  ..........................................  N  ...........  D  ................... 
m.v-x  (C311) 
NTV-  1,  WI'V- 6 
NTY-$ 
NTV-15 
3  .............................................  ￿9 .....  P  ...................................  D  ................ o.. 
3  .............................................................  ￿9 ............................  D  ................... 
"4  .............................................................  ~  ..................  IS ............................. 
3  ...........................  I  ................  N  .............................................  D  ................... 
M'I~-  I 
NT~t.--  9 
11  ..........................................................................  o ................................... 
5,11  ............  A ...................................................................  IS  ............................. 
Comm~nmzJ 




14,15  ...............................  V  ..................  K  ..............  Z  ........  TT  ........  X  ......................... 
14  ￿9 ￿9 .I-  .L .........  K  ..............  V  ..................  X  ............  K.I  ..................  K  .............  R  ........... 
m.v-1  (C311) 
N'fV- 1,  MTV-6 
NTV-3 
MTV-13 
5  ￿9 ￿9 .L ..................  II .........  M ........................................  R .......  R .... AL ...................... 
3  ￿9 ￿9 -L  ..................  It .........  N  ........................................  R  .......  R  ....  AL ...................... 
3  ........................................  P ..................................  T .....  g .... AL ...................... 
3  ..-L  ..................  IS .........  M ........................................  R .......  R .... AL ...................... 
MTV-8 
NTV-9 
11  ￿9  ￿9  -L  ............................  N  ........................................  R  .......  R  ....  TL  ...................... 
5,11  ....  Y  ...........................  I  .......  P  .......................  A.K  ......  IS-T  .................................. 
COnleX1811B 
a3o  240  25o  260  270  28o  39o  300  31o  32o 
DAP~YnMII~RII~I'VNGYI~LYR8I,  PI~]ntLA.qJU~PI~-W~TOlnM~D][M~QQV]~[~I"YLGTGN  WGKZI~  'I~IIGAVA  LZlfl[ZBA  T  GI~YIIG* 
NTV-C3H 
N'I'V-GR 
14,15  .............  W ..............................  M.IS  ......................  i~  ...........  T-.G  ....  Y-  -K-Y  ....  Yll. 
14  .............  W .....  Z  ........................  M..]IX  ....................  I~.  -  .V  ..........  O  ....  Y-  -X.Y  ....  YD. 
NTY-I  (C3") 
MTV-1,  NTY-6 
M'I~- $ 
NTV-13 
3  ..............................................  IS ......................  "rE--  ￿9 V  ￿9 YNSR  ￿9 J-  laug'r  ....  1[- I~* 
3  ..............................................  IS ......................  Zli-  -  ￿9 V  ￿9 YNISR ￿9 M- ][~.H'r ....  K- L,  PLa~* 
3  .....................................................................  "rlI.-  .V.  YNSR.  M.XRI~  ....  g.  LPLTIr* 
3  ..............................................  IS ......................  ZH.-  .V.  YMSR-  II-KRIII  ....  g.  LPLAFe 
NTV-9 
NTV-11 
11  .....................................................  I  ...............  l~  ......  Y  .......  RQr  .....  n-It  ....... 
5,11  ..............  N  ......................................................  NV ......  y  .......  R.r.  .....  D.F  ....... 
11  .......................  1  ris ......................  NV ......  Y  .......  ~r.  .....  D.lr  ....... 
Figure 4.  Comparison of amino acid sequences for MTV viral superantigens.  The consensus  sequence was derived from the published MTV vSAG 
sequences  (36,  38-41). 
The finding that all the MTV vSAGs that stimulate V~3 + 
cells have similar sequences,  which differ significantly from 
the other MTV vSAG sequences at the 3' end, strengthens 
the hypothesis that the 3' end of the MTV ORF encodes 
the VB-binding portion of the vSAGs (Fig. 4). This hypoth- 
esis is currently being further tested by analyzing T cell re- 
sponses to chimeric vSAGs. 
B cell transfectants expressing the Mtv-1 and Mtv-3 vSAGs 
were generated to test whether the products of these genes 
stimulate VB3-bearing T cells. CH12.1, a B cell lymphoma 
derived from B10.A (28), was used as the recipient cell line. 
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Since B10 congenic mice have high levels of V~3 expression 
(4, 34), we inferred that this B cell would not carry any V~/3- 
reactive MTV integrants  that might confound the results. 
Transfectants expressing Mtv-1 vSAG or Mtv-3 vSAG stimu- 
lated V~3 + T  call hybrids,  K25-49.16  (Table 2) and K25- 
59.6, while transfectants expressing  the hybrid vSAG C3H 
construct (pUVH) alone did not stimulate these T cells (data 
not shown). Thus, in conclusion, these experiments confirm 
that the vSAGs of these endogenous MTV integrants are su- 
perantigens, as has been previously demonstrated  for the in- 
fectious MTVs. Table  2.  Stimulation of VB3 § T  Cell Hybrids by 
Transfectants Expressing Mtv-10RF or MW-3 0RF 
IL-2 production by T  cell hybrids 
K25-49.16 




CMTV1-25  80  -* 
CMTV1-35  160  - 
CMTV1-40  320  - 
CMTV1-43  160  - 
CMTV3-4  640  - 
CMTV3-8  320  - 
CMTV3-27  320  - 
CMTV3-4.4t  160  - 
CMTV3-4.5#  640  - 
CMTV3-4.7t  640  - 
" gl0 U of IL-2/ml. 
* These transfectants are clones of CMTV3-4. 
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